Report Detail
Global and United States Oral Antiviral Medicine Market Report & Forecast 2022-2028
- RnM4423215 |
- 15 April, 2022 |
- Global |
- 96 Pages |
- QYResearch |
- Pharma & Healthcare
Summary:
Market Analysis and Insights: Global and United States Oral Antiviral Medicine Market
This report focuses on global and United States Oral Antiviral Medicine market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Oral Antiviral Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Tablet accounting for % of the Oral Antiviral Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Oral Antiviral Medicine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Oral Antiviral Medicine Scope and Market Size
Oral Antiviral Medicine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Oral Antiviral Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Oral Antiviral Medicine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Oral Antiviral Medicine market is segmented into
Tablet
Capsule
Segment by Application, the Oral Antiviral Medicine market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Oral Antiviral Medicine Market Share Analysis
Oral Antiviral Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Antiviral Medicine business, the date to enter into the Oral Antiviral Medicine market, Oral Antiviral Medicine product introduction, recent developments, etc.
The major vendors covered:
Pfizer
VEKLURY (Remdesivir)
MSD
GSK
Regeneron
Table of Contents
1 Study Coverage
- 1.1 Oral Antiviral Medicine Product Introduction
- 1.2 Global Oral Antiviral Medicine Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Oral Antiviral Medicine Sales in US$ Million for the Year 2017-2028
- 1.2.2 Global Oral Antiviral Medicine Sales in Volume for the Year 2017-2028
- 1.3 United States Oral Antiviral Medicine Outlook 2017 VS 2022 VS 2028
- 1.3.1 United States Oral Antiviral Medicine Sales in US$ Million for the Year 2017-2028
- 1.3.2 United States Oral Antiviral Medicine Sales in Volume for the Year 2017-2028
- 1.4 Oral Antiviral Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4.1 The Market Share of United States Oral Antiviral Medicine in Global, 2017 VS 2022 VS 2028
- 1.4.2 The Growth Rate of Oral Antiviral Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.5 Oral Antiviral Medicine Market Dynamics
- 1.5.1 Oral Antiviral Medicine Industry Trends
- 1.5.2 Oral Antiviral Medicine Market Drivers
- 1.5.3 Oral Antiviral Medicine Market Challenges
- 1.5.4 Oral Antiviral Medicine Market Restraints
- 1.6 Study Objectives
- 1.7 Years Considered
2 Market by Type
- 2.1 Oral Antiviral Medicine Market Segment by Type
- 2.1.1 Tablet
- 2.1.2 Capsule
- 2.2 Global Oral Antiviral Medicine Market Size by Type
- 2.2.1 Global Oral Antiviral Medicine Sales in Value, by Type (2017, 2022 & 2028)
- 2.2.2 Global Oral Antiviral Medicine Sales in Volume, by Type (2017, 2022 & 2028)
- 2.2.3 Global Oral Antiviral Medicine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
- 2.3 United States Oral Antiviral Medicine Market Size by Type
- 2.3.1 United States Oral Antiviral Medicine Sales in Value, by Type (2017, 2022 & 2028)
- 2.3.2 United States Oral Antiviral Medicine Sales in Volume, by Type (2017, 2022 & 2028)
- 2.3.3 United States Oral Antiviral Medicine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
- 3.1 Oral Antiviral Medicine Market Segment by Application
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Oral Antiviral Medicine Market Size by Application
- 3.2.1 Global Oral Antiviral Medicine Sales in Value, by Application (2017, 2022 & 2028)
- 3.2.2 Global Oral Antiviral Medicine Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 Global Oral Antiviral Medicine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
- 3.3 United States Oral Antiviral Medicine Market Size by Application
- 3.3.1 United States Oral Antiviral Medicine Sales in Value, by Application (2017, 2022 & 2028)
- 3.3.2 United States Oral Antiviral Medicine Sales in Volume, by Application (2017, 2022 & 2028)
- 3.3.3 United States Oral Antiviral Medicine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oral Antiviral Medicine Competitor Landscape by Company
- 4.1 Global Oral Antiviral Medicine Market Size by Company
- 4.1.1 Top Global Oral Antiviral Medicine Manufacturers Ranked by Revenue (2021)
- 4.1.2 Global Oral Antiviral Medicine Revenue by Manufacturer (2017-2022)
- 4.1.3 Global Oral Antiviral Medicine Sales by Manufacturer (2017-2022)
- 4.1.4 Global Oral Antiviral Medicine Price by Manufacturer (2017-2022)
- 4.2 Global Oral Antiviral Medicine Concentration Ratio (CR)
- 4.2.1 Oral Antiviral Medicine Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oral Antiviral Medicine in 2021
- 4.2.3 Global Oral Antiviral Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Oral Antiviral Medicine Manufacturing Base Distribution, Product Type
- 4.3.1 Global Oral Antiviral Medicine Manufacturers, Headquarters and Distribution of Producing Region
- 4.3.2 Manufacturers Oral Antiviral Medicine Product Type
- 4.3.3 Date of International Manufacturers Enter into Oral Antiviral Medicine Market
- 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 4.5 United States Oral Antiviral Medicine Market Size by Company
- 4.5.1 Top Oral Antiviral Medicine Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Oral Antiviral Medicine Revenue by Players (2020, 2021 & 2022)
- 4.5.3 United States Oral Antiviral Medicine Sales by Players (2020, 2021 & 2022)
5 Global Oral Antiviral Medicine Market Size by Region
- 5.1 Global Oral Antiviral Medicine Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Oral Antiviral Medicine Market Size in Volume by Region (2017-2028)
- 5.2.1 Global Oral Antiviral Medicine Sales in Volume by Region: 2017-2022
- 5.2.2 Global Oral Antiviral Medicine Sales in Volume Forecast by Region (2023-2028)
- 5.3 Global Oral Antiviral Medicine Market Size in Value by Region (2017-2028)
- 5.3.1 Global Oral Antiviral Medicine Sales in Value by Region: 2017-2022
- 5.3.2 Global Oral Antiviral Medicine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Oral Antiviral Medicine Market Size YoY Growth 2017-2028
- 6.1.2 North America Oral Antiviral Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Oral Antiviral Medicine Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Oral Antiviral Medicine Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Oral Antiviral Medicine Market Size YoY Growth 2017-2028
- 6.3.2 Europe Oral Antiviral Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Oral Antiviral Medicine Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Oral Antiviral Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.4.6 Colombia
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Oral Antiviral Medicine Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Oral Antiviral Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 Pfizer
- 7.1.1 Pfizer Corporation Information
- 7.1.2 Pfizer Description and Business Overview
- 7.1.3 Pfizer Oral Antiviral Medicine Sales, Revenue and Gross Margin (2017-2022)
- 7.1.4 Pfizer Oral Antiviral Medicine Products Offered
- 7.1.5 Pfizer Recent Development
- 7.2 VEKLURY (Remdesivir)
- 7.2.1 VEKLURY (Remdesivir) Corporation Information
- 7.2.2 VEKLURY (Remdesivir) Description and Business Overview
- 7.2.3 VEKLURY (Remdesivir) Oral Antiviral Medicine Sales, Revenue and Gross Margin (2017-2022)
- 7.2.4 VEKLURY (Remdesivir) Oral Antiviral Medicine Products Offered
- 7.2.5 VEKLURY (Remdesivir) Recent Development
- 7.3 MSD
- 7.3.1 MSD Corporation Information
- 7.3.2 MSD Description and Business Overview
- 7.3.3 MSD Oral Antiviral Medicine Sales, Revenue and Gross Margin (2017-2022)
- 7.3.4 MSD Oral Antiviral Medicine Products Offered
- 7.3.5 MSD Recent Development
- 7.4 GSK
- 7.4.1 GSK Corporation Information
- 7.4.2 GSK Description and Business Overview
- 7.4.3 GSK Oral Antiviral Medicine Sales, Revenue and Gross Margin (2017-2022)
- 7.4.4 GSK Oral Antiviral Medicine Products Offered
- 7.4.5 GSK Recent Development
- 7.5 Regeneron
- 7.5.1 Regeneron Corporation Information
- 7.5.2 Regeneron Description and Business Overview
- 7.5.3 Regeneron Oral Antiviral Medicine Sales, Revenue and Gross Margin (2017-2022)
- 7.5.4 Regeneron Oral Antiviral Medicine Products Offered
- 7.5.5 Regeneron Recent Development
8 Industry Chain and Sales Channels Analysis
- 8.1 Oral Antiviral Medicine Industry Chain Analysis
- 8.2 Oral Antiviral Medicine Key Raw Materials
- 8.2.1 Key Raw Materials
- 8.2.2 Oral Antiviral Medicine Distributors
- 8.3 Oral Antiviral Medicine Production Mode & Process
- 8.4 Oral Antiviral Medicine Sales and Marketing
- 8.4.1 Oral Antiviral Medicine Sales Channels
- 8.4.2 Oral Antiviral Medicine Distributors
- 8.5 Oral Antiviral Medicine Customers
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.2 Data Source
- 10.2 Author Details
Summary:
Get latest Market Research Reports on Oral Antiviral Medicine. Industry analysis & Market Report on Oral Antiviral Medicine is a syndicated market report, published as Global and United States Oral Antiviral Medicine Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Oral Antiviral Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
